Affordable Medicines For The Developing World
EDM number 753 in 2006-07, proposed by Lynne Featherstone on 25/01/2007.
That this House notes with concern that the European company Novartis, the makers of the anti-leukaemia drug Glivec, has brought a case against the Indian government to prevent manufacturers of generic medicines from producing low-cost copies of that drug; further notes that the generic medicines produced in India are essential treatments for many people in the developing world, especially those living with HIV/AIDS, and that millions of people rely on drugs produced in India for affordable medicines; and therefore urges Novartis to withdraw its action.
This motion has been signed by a total of 56 MPs.
Download raw data as csv or xml.